SILKIS

This brand name is authorized in Canada, Spain, Finland, France, Hong Kong, Ireland, Netherlands, Singapore, United Kingdom

Active ingredients

The drug SILKIS contains one active pharmaceutical ingredient (API):

1 Calcitriol UNII FXC9231JVH - CALCITRIOL

Calcitriol is the most active known form of vitamin D3 in stimulating intestinal calcium transport. In physiological amounts it augments the intestinal absorption of calcium and phosphate and plays a significant part in the regulation of bone mineralisation. Read about Calcitriol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SILKIS Ointment	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX03	Calcitriol	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02338572
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64527
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 592147
Country: FR	Base de données publique des médicaments	Identifier(s): 62597239
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26686
Country: HK	Department of Health Drug Office	Identifier(s): 50580
Country: IE	Health Products Regulatory Authority	Identifier(s): 45913
Country: NL	Z-Index G-Standaard	Identifier(s): 14554747
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 56014
Country: SG	Health Sciences Authority	Identifier(s): 12160P